- Home
- OMH vs DXR Comparison
OMH vs DXR Comparison
Compare OMH & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- DXR
- Stock Information
- Founded
- OMH 2015
- DXR 1970
- Country
- OMH Singapore
- DXR United States
- Employees
- OMH N/A
- DXR N/A
- Industry
- OMH Real Estate
- DXR Medical/Dental Instruments
- Sector
- OMH Finance
- DXR Health Care
- Exchange
- OMH Nasdaq
- DXR Nasdaq
- Market Cap
- OMH 35.8M
- DXR 36.4M
- IPO Year
- OMH 2023
- DXR N/A
- Fundamental
- Price
- OMH $1.42
- DXR $9.50
- Analyst Decision
- OMH Hold
- DXR Strong Buy
- Analyst Count
- OMH 1
- DXR 1
- Target Price
- OMH N/A
- DXR $25.00
- AVG Volume (30 Days)
- OMH 147.1K
- DXR 5.5K
- Earning Date
- OMH 07-25-2025
- DXR 01-01-0001
- Dividend Yield
- OMH N/A
- DXR N/A
- EPS Growth
- OMH N/A
- DXR 86.16
- EPS
- OMH N/A
- DXR 0.11
- Revenue
- OMH $7,976,578.00
- DXR $119,714.00
- Revenue This Year
- OMH $28.40
- DXR N/A
- Revenue Next Year
- OMH $23.07
- DXR N/A
- P/E Ratio
- OMH N/A
- DXR $85.83
- Revenue Growth
- OMH 117.53
- DXR N/A
- 52 Week Low
- OMH $0.59
- DXR $6.55
- 52 Week High
- OMH $6.20
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- OMH 47.16
- DXR 56.15
- Support Level
- OMH $1.41
- DXR $8.75
- Resistance Level
- OMH $1.56
- DXR $9.90
- Average True Range (ATR)
- OMH 0.10
- DXR 0.52
- MACD
- OMH 0.03
- DXR -0.07
- Stochastic Oscillator
- OMH 63.90
- DXR 67.21
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.